Fingerprint
Dive into the research topics of 'Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and imatinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically